Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by O'Connor Donal, Director. Officer active across 2 companies, notably PERRIGO Co plc. Aggregated, 11 filings have been published. History available since 7 May 2021. The latest transaction was disclosed on 14 May 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations
Donal O'Connor is a Board Member at Perrigo Co plc and Theravance Biopharma, Inc. In these roles, he participates in the governance and strategic decision-making of the companies. Donal contributes to policy development and strategic direction, ensuring that the companies meet their objectives while adhering to ethical and compliance standards. His experience is a valuable asset to the boards.